Læknaneminn - 01.10.1956, Blaðsíða 26

LÆKN AN EMINN
2<!
Therapy wíth IVIVSTECLIIM
Steclin — Mycostatin (Squibb Tetracycline — Nystatin)
the safest, broadest spectrum antibiotic preparation
Therapy with the usual broad spectrum antibiotics frequently
gives rise to an overgrowth of Candida albicans (monilia)
since none of these agents has any antifungal activity. Man-
ifestations of monilial overgrowth may include some of the
diarrhea and anal pruritus associated with such therapy, as
well as vaginal moniliasis and thrush. On occasion, serious
and even fatal systemic infections caused by monilia may occur.
Therapy with Mysteclin not only is effective in many comm-
on infections, but also protects the patient against the monilial
overgrowth. Because Mysteclin contains Mycostatin (Squibb
Nystatin), the first safe antifungal antibiotic, as well as Steclin
(Squibb Tetracycline), the well tolerated broad spectrum anti-
biotic, it is the only antibiotic preparation to offer this added
protection.
Mysteclin kapsúlan inniheldur 250 mg Tetracyclin
hcl. (Steclin) og 250.000 einingar Nystatin (Myco-
statin).
Minnsti skammtur fullorðinna: 1 kapsúla X4.
Pökkun: Flöskur á 12 stk. og 100 stk.
Heildsölubirgðir: PHARMACO H.F.
P. O. Box 1077, Reykiavík.
Umboðsmenn: O. JOHNSON & KAABER H.F.